Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detection of Genetic Markers of Lung Cancer Initiation and Progression

NCT00280202 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT00280202
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00280202 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detection of Genetic Markers of Lung Cancer Initiation and Progression
Lead sponsor
University of Pittsburgh
Phase
Observational
Overall status
Recruiting
Start date
June 30, 1996
Completion date
December 31, 2050
Enrollment
6,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer